Trial Profile
A Multicenter, Randomized, Double-blind, Placebo-controlled Study of the Hemodynamic Effects of Rolofylline Injectable Emulsion in the Treatment of Patients With Heart Failure
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Rolofylline (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- Sponsors Merck Sharp & Dohme Corp.
- 20 Apr 2012 Official title amended as reported by European Clinical Trials Database.
- 17 Mar 2012 Additional locations (Czech Republic, Germany, Italy) added as reported by European Clinical Trials Database.
- 17 Mar 2012 Planned number of patients changed from 16 to 66 as reported by European Clinical Trials Database.